
The 2 surprising factors that ‘increase your breast cancer risk' as Kara Tointon reveals brave mastectomy
Yesterday, former EastEnders star Kara Tointon revealed she's taken the decision to have a double mastectomy after discovering she carries a gene that increases her risk. But did you know, there are everyday factors that can influence your chances of the disease - including your height?
8
8
The 41-year-old posted an Instagram video to raise awareness of the preventative measure, after discovering she was at risk of both breast and ovarian cancer.
She said: "You may have heard of the BRCA genes 1 and 2 and as a carrier it means I am at a greater risk of both breast and ovarian cancer."
The soap star was asked to take a genetics test when her mum Carol was undergoing treatment for ovarian cancer back in 2018.
Sadly, her mum died in 2019.
After having her second son in 2021 and deciding her family was complete, she underwent two preventative surgeries - the first a double mastectomy and the second a two-part procedure involving the removal of the fallopian tubes and later the ovaries.
BRCA stands for BReast CAncer. It refers to the BRCA1 and BRCA2 genes, which are tumor suppressor genes that play a role in DNA repair and preventing uncontrolled cell growth.
When these genes have alterations (mutations), it can increase the risk of developing breast cancer and other cancers.
According to Dr Deborah Lee, of Dr Fox Online Pharmacy, women who carry abnormal BRAC 1 and BRAC2 genes have an 85 per cent increased lifetime risk of breast cancer.
She added: "Breast cancer is more likely to occur at an earlier age and to affect both breasts.
"The risk of ovarian cancer is also increased."
Individuals are at a higher risk of carrying BRCA1 or BRCA2 gene mutations if they have a family history of breast, ovarian, or prostate cancer, particularly if multiple close relatives have been diagnosed.
If you think you could be at risk, Dr Lee advises seeing your GP.
She said: "After a consultation, you may be referred for predictive genetic testing.
"There are pros and cons of having the predictive test and not everyone will want to have it.
"Before you have the test, you will be offered genetic counselling. The test is a blood test."
Two risk factors that might surprise you
BRCA genes aren't the only risk factor for breast cancer.
Dr Kerri Palmer-Quinn, senior scientific research officer at Breast Cancer UK, says the biggest risk factor is ageing - something we unfortunately cannot control.
Like many cancers, family history of the disease and various lifestyle and environmental factors can also influence your risk
But other risk factors for breast cancer may surprise you.
Being tall
Studies suggest there's a slight link between height and breast cancer risk, with taller women potentially having a slightly higher chance of developing the disease.
Dr Palmer-Quinn said: "Being tall can slightly increase your risk of breast cancer.
"The reasons behind this association are still being investigated, however it may be linked to the growth spurts taller woman have during early development.
"These growth spurts mean that taller women may have higher levels of certain growth factors as well as the growth hormone insulin-like growth factor 1 (IGF-1).
"IGF-1 can promote cell growth and prevent programmed cell death which can increase the risk of cancer, including breast cancer."
High breast density
8
Having high breast density (also known as mammographic density) is a strong risk factor for breast cancer.
Dr Palmer-Quinn explained: "having dense breasts means you have higher proportions of fibrous and glandular tissue which is where breast cancers are more likely to arise, in comparison to fat tissue.
"Breast density can only be determined by a mammogram scan and isn't related to how your breasts look or feel.
"Having dense breasts can make these mammogram scans more difficult to interpret meaning potential cancers are harder to identify.
"Breast density can be influenced by your genetics and potentially the environment; it also may change overtime and tends to reduce with age."
Other risk factors to be aware of
While some breast cancer risk factors are unavoidable, including age, others are modifiable and can be addressed to potentially lower your risk.
Weight gain throughout adulthood
Weight gain throughout adulthood increases the risk of postmenopausal breast cancer; particularly if the weight gain occurs after menopause has taken places, advised Dr Palmer-Quinn.
She added: "After menopause, the body's production of the sex hormone oestrogen shifts from the ovaries to fat tissue. Therefore, increased body fat can lead to higher levels of circulating oestrogen, which is a known risk factor for breast cancer.
"In addition, excess body fat can contribute to chronic inflammation and disrupt hormone regulation in ways that may further increase breast cancer risk."
What you can do: To maintain a healthy weight, focus on a balanced diet, regular physical activity, and healthy lifestyle habits. Prioritise fruits, vegetables, whole grains, and lean proteins, and limit sugary drinks and processed foods. Aim for at least 150 minutes of moderate-intensity aerobic exercise per week.
Alcohol consumption
8
Any level of alcohol consumption can increase the risk of developing breast cancer - there is no safe threshold.
Dr Palmer-Quinn explained: "Alcohol raises levels of circulating oestrogen.
"It is also broken down into acetaldehyde, a compound that can damage DNA and potentially lead to cancer.
"Additionally, alcohol can contribute to weight gain, which may further increase risk, particularly after menopause."
What you can do: When it comes to giving up alcohol it can help to tell your family and friends that you're aiming to stop drinking alcohol and explain why. This way, you can share your successes with them, and they'll understand why you've started turning down drinks or trips to the pub. Try to identify the times when you would usually drink and fill the gap with something else. And remember to enjoy the benefits, including weight loss, better sleep, and more energy.
Smoking
Studies have shown a small but statistically significant increased risk of breast cancer in women who smoke compared to those who have never smoked.
Dr Lee said: "Current smoking increases the risk of breast cancer by 10 per cent compared to those who have never smoked."
What you can do: The most effective way to quit smoking is to combine nicotine replacement therapy (NRT) or other medications with professional support from a local stop smoking service.
Lack of exercise
A lack of physical activity is a well-established risk factor for breast cancer.
Dr Lee explained: "Regular physical activity has been shown to reduce the risk of breast cancer by around 20 per cent.
"Exercise lowers hormone levels and reduces inflammation as well as helping control body weight."
What you can do: To begin exercising, start with low-impact activities like brisk walking, swimming, or yoga, and gradually increase intensity and duration. Set realistic goals, choose activities you enjoy, and schedule exercise into your routine. Consider finding an exercise buddy, using a journal or app to track progress, and varying your workouts to stay motivated.
As well as doing what you can to reduce your risk of breast cancer, make sure you're well aware of the symptoms to look out for - see a GP if you experience any of the below...
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


ITV News
10 minutes ago
- ITV News
UK-India trade deal sparks fears over access to cheap medicines for millions
A newly signed trade agreement between India and the UK has triggered concerns that millions of poor Indians may lose access to affordable life-saving medicines. Civil society groups and health experts say the UK-India Free Trade Agreement (FTA), finalised between two countries, tilts the balance in favour of multinational pharmaceutical corporations and threatens to erode long-standing protections that have allowed India to produce low-cost generic drugs. 'This is not just about trade. It's about whether a person living on ₹200 (£2) a day can afford cancer treatment or survive tuberculosis,' said Jyotsna Singh, co-convenor of the Working Group on Access to Medicines and Treatments. At the heart of the controversy are the agreement's intellectual property (IP) provisions, which activists say may restrict the Indian government's ability to issue compulsory licences—legal tools that allow domestic companies to manufacture patented drugs at reduced prices during public health emergencies. India used this provision in 2012 to dramatically cut the price of sorafenib, a cancer drug sold by Bayer under the brand Nexavar. Generic versions slashed the monthly cost by nearly 97%, from ₹2.8 lakh (£2,600) to around ₹8,800 (£80), making it affordable to thousands. 'By discouraging compulsory licensing and promoting voluntary licences, the deal hands over control of access to medicines to the market,' said Prof Biswajit Dhar, a trade expert and former professor at New Delhi's Jawaharlal Nehru University. 'Voluntary licences often come with strings attached and don't bring the same price reductions.' Weakening India's Patent Safeguards Under the FTA, companies will no longer need to report annually how their patents are being 'worked'—or used—in India. Instead, disclosures can be made every three years, and some information can be kept confidential. Activists say this undermines transparency and makes it harder to prove that a drug isn't available to the public, a key step in applying for a compulsory licence. There are also concerns the deal could open the door to 'evergreening'—a tactic in which companies make minor changes to existing drugs and claim new patents. Indian law currently limits this practice under Section 3(d) of the Patents Act, but experts warn the FTA's emphasis on 'harmonisation' of IP standards with Western countries could override such protections. 'This is effectively a backdoor entry for TRIPS-plus provisions,' said K.M. Gopakumar, co-convenor of the Working Group. 'It would push India to grant unnecessary patents, prolonging monopolies and delaying cheaper alternatives.' The Indian pharmaceutical industry supplies more than 60% of global vaccines and a significant share of affordable generics to low- and middle-income countries. Critics say the FTA may limit this capacity and ultimately have consequences well beyond India's borders. Government response The Indian government has promoted the FTA as a landmark deal that will boost exports and attract UK investment in manufacturing, services, and digital trade. Officials insist that India has preserved its ability to protect public health. But rights groups remain unconvinced. 'You cannot negotiate away access to life-saving drugs in the name of free trade,' said Gargeya Telakapalli, a public health campaigner based in Hyderabad. 'The poorest Indians—those with cancer, HIV, diabetes, or TB—are being quietly sacrificed.' Broader implications The deal follows a similar agreement India signed last year with the European Free Trade Association (EFTA), which also faced criticism for diluting IP safeguards. Observers say the trend may reflect a shift in India's trade policy as it seeks closer ties with Western economies. But for many in India's healthcare and legal communities, the question remains: how much access to medicine is the country willing to give up for a better trade balance? From Westminster to Washington DC - our political experts are across all the latest key talking points. Listen to the latest episode below...


Metro
40 minutes ago
- Metro
Health warning over counterfeit vodka made with medical-grade alcohol
Health officials in Scotland have warned fans of Glen's vodka to keep an eye out for fake half bottles containing medical disinfectant. Scammers have hijacked the popular brand to sell counterfeit products containing the chemical isopropyl, which is typically used in hospital settings or in hand sanitiser. Food Standards Scotland (FSS) say the fake booze will smell and taste 'very different' to the Glen's product people recognise. Even small amounts of isopropyl can result in abdominal pain, vomiting, dizziness and headaches, they warned. Severe cases can leave drinkers in a coma or even dead. Genuine bottles of Glen's have a laser-etched code between the rear label and the base of the bottle which the fake bottles will not. More Trending Anyone concerned they might have drunk the counterfeit vodka, and who is experiencing symptoms, is urged to contact NHS 24 on 111 immediately. Glen's, one of the cheaper brands of vodka on the market, is a popular target for scammers. FSS has previously sent investigators to seize dozens of bottles of fake spirit using the same label from a shop in Coatbridge, Lanarkshire. And in September last year, the UK-wide Food Standards Agency sent out a warning about another fraud involving isopropyl alcohol in Glen's bottles. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: The one drink you should never order from a restaurant wine list MORE: How a generation-bending TikTok campaign saved a local boozer MORE: Forget about Prosecco — drink this £6.97 sparkling wine from Asda instead


The Independent
40 minutes ago
- The Independent
NHS: Strike-hit appointments to be rebooked in two weeks but will impact others
NHS England has said hospitals are aiming to reschedule appointments cancelled due to strikes within two weeks, but warned of knock-on impacts for other patients. Professor Meghana Pandit, NHS England's co-national medical director (secondary care), said that despite the five-day walkout by thousands of resident doctors in England, which began on Friday, local trusts have managed to maintain services with 'minimal disruption'. She told BBC Breakfast: 'If there's any rescheduling or postponement of surgery or appointments then the hospitals try their upmost best to get that appointment rescheduled within two weeks. 'I know it is distressing and even two weeks is too long for somebody to wait and actually that has an impact on the people who who are then displaced at that two week period.' Prof Pandit said there were three 'derogations' granted on Friday, a process which allows hospitals to request striking doctors return to work if there is a risk to patient safety. Nottingham City Hospital reached an agreement with the British Medical Association (BMA) to exempt one doctor from the strike to work on the neonatal intensive care unit. A derogation was agreed for one doctor in the emergency department and another doctor in the ISGM at the Northern General Hospital. The BMA said it had also agreed a derogation for two anaesthetists to work at University Hospital Lewisham on Saturday to ensure patient safety. It comes as Wes Streeting said 'we are doing everything we can to minimise' patient harm. The Health Secretary condemned the strike as 'reckless' and said the Government would not allow the BMA to 'hold the country to ransom'. Sir Keir Starmer made a last-minute appeal to resident doctors, saying the strikes would 'cause real damage'. He added: 'Most people do not support these strikes. They know they will cause real damage… 'These strikes threaten to turn back the clock on progress we have made in rebuilding the NHS over the last year, choking off the recovery.' The BMA has argued that real-terms pay has fallen by around 20% since 2008, and is pushing for full 'pay restoration'.